NCT00496366 · Interventional trial
Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer
Overall registry status Terminated
Phase 2
Conditions Advanced Breast Cancer, Breast Cancer, HER2/Neu-positive Breast Cancer, Metastatic Breast Cancer
Delaware Valley sites
- Rutgers Cancer Institute of New Jersey at Hamilton · Hamilton, NJ · Mercer County
First posted
Registry updated
Added to the directory